Odyssey Therapeutics, Inc. balance sheet ODTX

As of Sep 30, 2026, Odyssey Therapeutics, Inc. had total assets of $438.1 million and total liabilities of $62.3 million. Stockholders' equity was $375.8 million. It held $387.0 million in cash and investments against $300,000 of total debt, net cash of $386.7 million. The current ratio, current assets divided by current liabilities, was 12.94.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

Line
FY 2026
Sep 30, 2026
Assets
Cash
81
Short-term investments
245
Long-term investments
61
Cash and investments
387
Receivables
0
Total current assets
338
Property and equipment, net
5
Goodwill
14
Total assets
438
Liabilities and equity
Accounts payable
8
Total current liabilities
26
Total liabilities
62
Stockholders' equity
376
Debt
Lease liabilities
0
Total debt
0
Net cash
387
Ratios
Current ratio
12.94x
Debt to equity
0.00x
Book value per share
7.84
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. The first column is the latest balance sheet when it is newer than the latest fiscal year. More on our methodology.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
ODTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boston, MA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1882782

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.